Glutathionylation-dependent proteasomal degradation of wide-spectrum mutant p53 proteins by engineered zeolitic imidazolate framework-8-Reference-Cited by-同舟云学术

Glutathionylation-dependent proteasomal degradation of wide-spectrum mutant p53 proteins by engineered zeolitic imidazolate framework-8

Published:2021-04 Issue: Volume:271 Page:120720
ISSN:0142-9612
Container-title:Biomaterials
language:en
Short-container-title:Biomaterials

Author:

Zhang Yunjiao,Huang Xiaowan,Wang Liansheng,Cao Cong,Zhang Hao,Wei Pengfei,Ding He,Song Yang,Chen Ziying,Qian Jieying,Zhong Suqin,Liu Zefeng,Wang Meimei,Zhang Wenbin,Jiang Wenwei,Zeng Jie,Yao Guangyu,Wen Long-ping

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Mechanics of Materials,Biomaterials,Biophysics,Ceramics and Composites,Bioengineering

Reference58 articles.

1. The p53 pathway: origins, inactivation in cancer, and emerging therapeutic approaches;Joerger;Annu. Rev. Biochem.,2016

2. p53 in survival, death and metabolic health: a lifeguard with a licence to kill;Kruiswijk;Nat. Rev. Mol. Cell Biol.,2015

3. p53 in health and disease;Vousden;Nat. Rev. Mol. Cell Biol.,2007

4. 30 years and a long way into p53 research;Hainaut;Lancet Oncol.,2009

5. Integrated genomic analyses of ovarian carcinoma;Cancer Genome Atlas Research;Nature,2011

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging roles of tripartite motif family proteins (TRIMs) in breast cancer;Cancer Medicine;2024-07

2. Nanoparticles (NPs)-mediated targeted regulation of redox homeostasis for effective cancer therapy;Smart Materials in Medicine;2024-06

3. Potential of the nanoplatform and PROTAC interface to achieve targeted protein degradation through the Ubiquitin–Proteasome system;European Journal of Medicinal Chemistry;2024-03

4. Engineered a dual-targeting HA-TPP/A nanoparticle for combination therapy against KRAS-TP53 co-mutation in gastrointestinal cancers;Bioactive Materials;2024-02

5. NIR Emissive Functional Nanoparticles Promote Precise Pancreatic Cancer Therapy by Co‐Targeting Mutant p53 and Oncogenic KRAS;Advanced Functional Materials;2024-01-25